The AI-powered symptom assessment and care navigation platform,
which gives 50M+ users access to its enterprise solutions, reaches
key growth milestones, achieving profitability, generating 260% YoY
revenue growth, and expanding global partnerships.
NEW
YORK and BERLIN,
June 6,
2024 /PRNewswire/ -- Ada Health Inc. ('Ada
Health'), along with its parent company, Ada Health GmbH, today
announced the expansion of its leadership team with Nick Altebrando joining as Chief Product Officer
and Yury Rozenman joining as Senior
Vice President of Business Development. The additions to its
leadership team follow a year of exponential growth. Ending 2023,
the company achieved profitability, generating a 260% increase in
revenue year over year due to new and expanded partnerships with
innovative healthcare systems and life sciences companies.
Ada's momentum arrives at a critical time in healthcare. The US
is facing the worst shortage of primary care providers on record –
as well as other clinicians – leading to new appointment wait times
averaging 20+ days. This delay in care may increase morbidity and
mortality risk among those with underlying and preventable
conditions. Extended wait times and poor access to care are drivers
for 9 out of 10 people searching their symptoms online before an
appointment, but this can result in unnecessary urgent care visits
or cause patients to overlook more serious symptoms that may
require emergency medical care.
Ada tackles these issues through its AI-powered symptom
assessment technology—which has been shown to be 35% more accurate
than other assessments—and its care navigation platform, which
directs users to the most appropriate level of care. Built on 13
years of R&D and with over 1 million hours of clinician time
invested into the platform's medical knowledge, Ada covers 3,600
conditions and 30,000 ICD-10 codes, including rare diseases,
women's health, pediatric, and mental health conditions.
As Ada addresses critical challenges within the healthcare
system, and on the heels of the company's continued growth, the new
hires will support various strategic initiatives that bolster the
brand, its products, and its partnerships.
"Bringing Nick and Yury on board is not just about
enhancing our team's capabilities; it's a pivotal move to deepen
our engagement with the healthcare ecosystem at a time when
reliable and safe AI is needed to support our overloaded system,"
said Daniel Nathrath, co-founder and CEO of Ada Health.
"Their expertise will be crucial in driving our initiatives
forward, ensuring that Ada Health continues to deliver exceptional
value in improving patient outcomes and tackling inefficiencies
within the healthcare system."
Nick Altebrando, Ada's new Chief Product Officer, brings
decades of experience leading strategic product innovation at
companies such as WebMD, Eko Health, and AbleTo. At WebMD, he was
the head of product innovation, leading an effort to connect
provider, payer, and consumer businesses.
"I've had Ada Health on my radar for years. The company has
already created a product that's improving patient outcomes while
supporting care teams—two of the biggest challenges facing our
healthcare system," said Nick
Altebrando, Chief Product Officer. "I'm eager to
identify new opportunities for Ada to continue evolving the product
to reach more people."
Yury Rozenman, the company's new
Senior Vice President of Business Development, previously served as
the Senior Vice President of Life Sciences Strategy and Business
Development at ResMed-owned Propeller Health. He has also served as
the Head of Business Development for Fitbit Health Solutions, where
he facilitated new partnerships that expanded diagnosis and
treatment pathways.
"I'm energized to join Ada at this transformative moment as we
harness cutting-edge AI to elevate healthcare delivery for millions
of people around the world," said Yury Rozenman, SVP of Business Development.
"Our strategy focuses on broadening our impact and forging new
pathways in global health markets, ensuring that every innovation
not only meets clinical needs but improves healthcare accessibility
and efficiency."
Ada's expansion to its leadership team follows several major
milestones in 2023, including the growth of its products,
partnerships, and AI.
- Product Innovations: Ada launched Care Journeys,
starting with a COVID-19 solution that guides high-risk patients to
telehealth consultations to help patients receive treatment, often
within two hours of using the screener. This is currently available
across all 50 US states and Washington
DC.
- Strategic Partnerships: Ada also expanded its
partnerships with the world's leading health systems, pharma
companies, foundations, payers, and governments, adding to its
already extensive roster that includes Jefferson Health, Novartis,
Bayer, Pfizer, and Orion Health. Additionally, Ada joined the U.S.
Business Action to End HIV Coalition and continues to partner with
the Health Action Alliance on women's health.
- Advancements in AI Technology: Ada continued to optimize
its AI with updates to its medical engine released every two weeks,
enhancing accuracy to identify conditions, including underdiagnosed
and rare diseases, and improving integration with electronic health
records.
With an expanded bench of industry experts, Ada will double down
on its focus on expanding commercial partnerships with health
systems, pharmaceutical companies, and payers, while enhancing key
product offerings.
About Ada Health
Ada Health is a global health company founded by doctors,
scientists, and industry pioneers to create new possibilities for
personal health and transform knowledge into better outcomes. Its
core system connects medical knowledge with intelligent technology
to help tens of millions of people actively manage their health and
health systems to deliver more effective care.
Ada Health's powerful AI-based health assessment platform helps
users better understand their mental and physical symptoms through
a thorough series of questions based on clinically validated AI and
protocols, and based on their responses, navigates them to the
appropriate, available services and support. The platform's medical
knowledge covers an industry-leading range of symptoms and
conditions, while the platform itself prioritizes user safety and
accuracy and is designed to be as inclusive as possible.
The company also works with a range of leading health providers
and organizations internationally to help direct users to the right
care, support overburdened systems, and help manage diseases with
the ultimate aims of improving health outcomes and delivering
seamless end-to-end healthcare journeys.
To learn more, visit www.ada.com.
Shireen Saxena
Director of External Affairs
Ada Health
shireen.saxena@ada.com
This release was issued through WebWire®. For more information,
visit http://www.webwire.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ada-health-the-most-accurate-ai-for-care-navigation-expands-its-leadership-team-for-strategic-growth-with-product-and-business-development-hires-302166540.html
SOURCE Ada Health